Pregnancy News and Research

Latest Pregnancy News and Research

Weill Cornell Medical College commences construction of 18-story, $650 million Medical Research Building

Weill Cornell Medical College today celebrated the start of construction on its new Medical Research Building, a state-of-the-art facility that will more than double the institution's existing research space. The 18-story, $650 million building is the centerpiece of Weill Cornell's $1.3 billion Discoveries that Make a Difference Campaign, the country's largest for a medical college. A total of $1 billion has been raised toward this goal in a record time of less than four years.

27 May 2010

Nurses use up-to-date techniques to help smokers quit, says RNAO

As World No Tobacco Day 2010 (May 31) approaches, Canadians thinking about quitting smoking can rely on nurses to help them butt out. The Registered Nurses' Association of Ontario says nurses are using the most up-to-date techniques to help smokers quit, which is reducing the number of smokers and preventing diseases.

26 May 2010

Study shows impact of pregnancy on the life of adolescent women

The effective use of contraception once becoming sexually active is the best way to avoid unwanted pregnancy during adolescence. This is just one of the conclusions of a study by the Spanish National Research Council and the Universidad Complutense in Madrid which additionally reveals that using no contraception or using it well after starting sexual relations increases up to six times the risk for teen pregnancy.

26 May 2010

POZEN receives milestone payment from AstraZeneca for FDA approval of VIMOVO

POZEN Inc., announced today the receipt of a $20 million milestone payment from AstraZeneca for the U.S. Food and Drug Administration approval of VIMOVO (naproxen and esomeprazole magnesium) delayed-release tablets on April 30th. POZEN will transfer ownership of the Investigational New Drug application and New Drug Application for VIMOVO to AstraZeneca over the next few weeks.

26 May 2010

Vical receives $4.0M grant to support development of novel vaccine for CMV infection

Vical Incorporated announced today that the company is collaborating with leading pediatric infectious disease researchers Stuart P. Adler, M.D., and Michael A. McVoy, Ph.D., of Virginia Commonwealth University under a five-year, approximately $4.0 million grant from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

25 May 2010

Folate supplementation thwarts heart birth defects induced by alcohol exposure in early pregnancy

A new animal study has found that high levels of the B-vitamin folate (folic acid) prevented heart birth defects induced by alcohol exposure in early pregnancy, a condition known as fetal alcohol syndrome.

25 May 2010

Bayer's Adalat XL product and Mylan's nifedipine extended release 60 mg not bioequivalent: Study

Bayer Inc. today responded to Professor Marvin Meyer's letter to the editor, entitled: "Critical questions concerning the validity of the Bayer study report of differences in bioavailability between 60 mg of nifedipine osmotic push-pull systems after fasted and fed administration" and published in the online edition of the International Journal of Clinical Pharmacology and Therapeutics. Bayer responded to the clinical relevance of the differences in formulation and dissolution behaviour and the delayed absorption of Mylan's extended release nifedipine.

25 May 2010

Combination therapy improves patients with depression symptoms: Study

New data presented today at the American Psychiatric Association's annual meeting suggests a benefit to combining L-methylfolate, a prescription medical food called Deplin, with an antidepressant at the start of treatment. This retrospective analysis showed a significantly greater improvement in depression symptoms in a shorter period of time, when patients with Major Depressive Disorder were started on combination therapy.

25 May 2010

Media outlets highlight studies presented at International Microbicides Conference

A study in Africa, presented Sunday at the International Microbicides Conference (M2010) in Pittsburgh, has shown that a man's risk of HIV infection doubles if his HIV-positive partner is pregnant, according to HealthDay News/U.S. News & World Report.

25 May 2010

New study indicates pregnancy can double HIV risk in men

Young women of reproductive-age are among those at greatest risk of acquiring HIV, and several studies have suggested that during pregnancy women are even more susceptible to infection.

24 May 2010

Women living in food insecure households more likely to experience health complications

A recent research study has shown that food insecurity, a person's inability to obtain adequate amounts of food due to resource constraints, can lead to greater weight gain and increased complications during a woman's pregnancy.

24 May 2010

New national standards issued for newborn screening

New national standards issued today will assist states to align their newborn screening programs with "the most up-to-date research, technology, laboratory and public health standards and practices."

24 May 2010

New data highlighting Pfizer's approach to cancer drug development to be presented at ASCO meeting

Pfizer Oncology will present new data highlighting the company's focused approach to cancer drug development through the identification and validation of molecular targets. These results will be presented at the 46th Annual American Society of Clinical Oncology meeting in Chicago from June 4-8.

21 May 2010

Vitamin D plays much wider role in people's life

Vitamin D is the sunshine vitamin - we make it when our skin is exposed to UV rays. In a perfect world everyone would eat fresh, organic foods, get outside, and enjoy a little sunshine all year round. But with today's busy lifestyles and concerns about skin cancer many people are vitamin D deficient and don't know it.

21 May 2010

Eli Lilly to present results of two Phase II trials evaluating ALIMTA in combination with chemotherapy, radiation

Results of two Phase II trials evaluating ALIMTA (pemetrexed for injection) in combination with a platinum chemotherapy and radiation for patients with locally advanced non-small cell lung cancer will be presented by Eli Lilly and Company at the 46th Annual Meeting of the American Society of Clinical Oncology in Chicago, Ill., on June 6, 2010.

21 May 2010

Genentech to present new data for targeted cancer medicines at 46th ASCO

Genentech, Inc., a wholly owned member of the Roche Group, today announced that it will present new data for its targeted cancer medicines and the way they may be used in several different cancer types at the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO). Approximately 400 abstracts featuring Genentech and Roche's cancer medicines and investigational agents across 30 cancer types will be presented during the meeting that is taking place June 4 to 8, 2010 in Chicago.

21 May 2010

US subsidiary of Novartis disputes claims of discrimination

Novartis Pharmaceuticals Corporation (NPC), a US subsidiary of Novartis AG, strongly disputes the claims of past discrimination in the sales force during the period of 2002 to 2007.

20 May 2010

Novartis to pay additional $250 million for gender discrimination inflicted on 5,600 working women

After delivering a unanimous verdict against Novartis on all counts and awarding 12 former Novartis sales reps $3.36 million in compensatory damages yesterday, a New York jury today delivered a stronger dose of the same medicine. Announcing the amount of punitive damages to be awarded, the jury determined that Novartis must pay an additional $250 million for the gender discrimination it inflicted on 5,600 working women in the class. The case was the largest gender discrimination matter ever to go to verdict in the U.S.

20 May 2010

Alere announces formation of Collaborative Care Solutions to support physicians, provider groups

With the goal of creating the industry standard for connecting patients and their physician-led care teams, Alere today announced the formation of a new strategic product line, Collaborative Care Solutions. The new product line will be focused on supporting physicians and provider groups wanting to expand their practices via patient-centered medical homes or accountable care organizations -- key care models designed to realize better outcomes and more cost-effective care.

19 May 2010

MEDNAX acquires neonatal physician group in Ft. Myers, Florida

MEDNAX, Inc., today announced that it has completed the acquisition of a neonatal physician group in Ft. Myers, Florida.

19 May 2010

Pregnancy News and Research

Latest Pregnancy News and Research

Weill Cornell Medical College commences construction of 18-story, $650 million Medical Research Building

Nurses use up-to-date techniques to help smokers quit, says RNAO

Study shows impact of pregnancy on the life of adolescent women

POZEN receives milestone payment from AstraZeneca for FDA approval of VIMOVO

Vical receives $4.0M grant to support development of novel vaccine for CMV infection

Folate supplementation thwarts heart birth defects induced by alcohol exposure in early pregnancy

Bayer's Adalat XL product and Mylan's nifedipine extended release 60 mg not bioequivalent: Study

Combination therapy improves patients with depression symptoms: Study

Media outlets highlight studies presented at International Microbicides Conference

New study indicates pregnancy can double HIV risk in men

Women living in food insecure households more likely to experience health complications

New national standards issued for newborn screening

New data highlighting Pfizer's approach to cancer drug development to be presented at ASCO meeting

Vitamin D plays much wider role in people's life

Eli Lilly to present results of two Phase II trials evaluating ALIMTA in combination with chemotherapy, radiation

Genentech to present new data for targeted cancer medicines at 46th ASCO

US subsidiary of Novartis disputes claims of discrimination

Novartis to pay additional $250 million for gender discrimination inflicted on 5,600 working women

Alere announces formation of Collaborative Care Solutions to support physicians, provider groups

MEDNAX acquires neonatal physician group in Ft. Myers, Florida

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Pregnancy News and Research

Latest Pregnancy News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in